These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98. von Neuhoff C; Reinhardt D; Sander A; Zimmermann M; Bradtke J; Betts DR; Zemanova Z; Stary J; Bourquin JP; Haas OA; Dworzak MN; Creutzig U J Clin Oncol; 2010 Jun; 28(16):2682-9. PubMed ID: 20439630 [TBL] [Abstract][Full Text] [Related]
5. Cytogenetic profile of a large cohort of Tunisian de novo acute myeloid leukemia. Gmidène A; Sennana H; Wahchi I; Youssef YB; Jeddi R; Elloumi M; Saad A Hematology; 2012 Jan; 17(1):9-14. PubMed ID: 22549442 [TBL] [Abstract][Full Text] [Related]
6. Myeloid Sarcoma Predicts Superior Outcome in Pediatric AML; Can Cytogenetics Solve the Puzzle? Pramanik R; Tyagi A; Chopra A; Kumar A; Vishnubhatla S; Bakhshi S Clin Lymphoma Myeloma Leuk; 2018 Jun; 18(6):e249-e254. PubMed ID: 29680411 [TBL] [Abstract][Full Text] [Related]
7. Clinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group. Klein K; Kaspers G; Harrison CJ; Beverloo HB; Reedijk A; Bongers M; Cloos J; Pession A; Reinhardt D; Zimmerman M; Creutzig U; Dworzak M; Alonzo T; Johnston D; Hirsch B; Zapotocky M; De Moerloose B; Fynn A; Lee V; Taga T; Tawa A; Auvrignon A; Zeller B; Forestier E; Salgado C; Balwierz W; Popa A; Rubnitz J; Raimondi S; Gibson B J Clin Oncol; 2015 Dec; 33(36):4247-58. PubMed ID: 26573082 [TBL] [Abstract][Full Text] [Related]
8. Specific chromosomal aberrations in de novo acute myeloid leukemia: a comparative analysis of results with a report of three novel chromosomal rearrangements t(7;14)(q35;q13), t(8;18)(p11.2;q12), t(13;15) in Indian population. Ahmad F; Dalvi R; Das BR; Mandava S Cancer Detect Prev; 2008; 32(2):168-77. PubMed ID: 18639991 [TBL] [Abstract][Full Text] [Related]
9. Low miR-192 expression predicts poor prognosis in pediatric acute myeloid leukemia. Tian C; Zhang L; Li X; Zhang Y; Li J; Chen L Cancer Biomark; 2018; 22(2):209-215. PubMed ID: 29689705 [TBL] [Abstract][Full Text] [Related]
10. Trisomy 21 with t(5; 11) chromosomal translocation as new unfavorable cytogenetic abnormalities in pediatric acute myeloid leukemia type M2: One case report of nine-year follow-up and literature review. Wang L; Wu XY; Jin RM; Zhang BY; Qiu YN J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):807-810. PubMed ID: 29058300 [TBL] [Abstract][Full Text] [Related]
11. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities. Gröschel S; Lugthart S; Schlenk RF; Valk PJ; Eiwen K; Goudswaard C; van Putten WJ; Kayser S; Verdonck LF; Lübbert M; Ossenkoppele GJ; Germing U; Schmidt-Wolf I; Schlegelberger B; Krauter J; Ganser A; Döhner H; Löwenberg B; Döhner K; Delwel R J Clin Oncol; 2010 Apr; 28(12):2101-7. PubMed ID: 20308656 [TBL] [Abstract][Full Text] [Related]
12. [Long-term survival results according to cytogenetic risk in patients with acute myeloid leukemia--singl center experience]. Piatkowska-Jakubas B; Mensah-Glanowska P; Salamańczuk Z; Skotnicki AB Przegl Lek; 2011; 68(6):291-5. PubMed ID: 22039664 [TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukaemia: expression of MYC protein and its association with cytogenetic risk profile and overall survival. Mughal MK; Akhter A; Street L; Pournazari P; Shabani-Rad MT; Mansoor A Hematol Oncol; 2017 Sep; 35(3):350-356. PubMed ID: 26856970 [TBL] [Abstract][Full Text] [Related]
14. [Analyses of karyotypic characteristics and prognosis in pediatric acute myeloblastic leukemia]. Ruan M; Wang YQ; Zhang L; Zou Y; Zhu XF Zhonghua Xue Ye Xue Za Zhi; 2012 Sep; 33(9):725-8. PubMed ID: 23336225 [TBL] [Abstract][Full Text] [Related]
15. Biological and clinical significance of cytogenetic study on 100 acute lymphoblastic leukemia and 219 acute non-lymphoblastic leukemia. Ye J; Cao Q; Su X; Huang Q; Ma Z; Wang Z; Huang W; Chen Z; Chen S Chin Med J (Engl); 1997 Feb; 110(2):90-5. PubMed ID: 9594276 [TBL] [Abstract][Full Text] [Related]
16. Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groups. Creutzig U; Zimmermann M; Reinhardt D; Rasche M; von Neuhoff C; Alpermann T; Dworzak M; Perglerová K; Zemanova Z; Tchinda J; Bradtke J; Thiede C; Haferlach C Cancer; 2016 Dec; 122(24):3821-3830. PubMed ID: 27529519 [TBL] [Abstract][Full Text] [Related]
17. Cytogenetic profile of de novo acute myeloid leukemia: a study based on 1432 patients in a single institution of China. Cheng Y; Wang Y; Wang H; Chen Z; Lou J; Xu H; Wang H; Qian W; Meng H; Lin M; Jin J Leukemia; 2009 Oct; 23(10):1801-6. PubMed ID: 19474801 [TBL] [Abstract][Full Text] [Related]
18. Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004. Rasche M; von Neuhoff C; Dworzak M; Bourquin JP; Bradtke J; Göhring G; Escherich G; Fleischhack G; Graf N; Gruhn B; Haas OA; Klingebiel T; Kremens B; Lehrnbecher T; von Stackelberg A; Tchinda J; Zemanova Z; Thiede C; von Neuhoff N; Zimmermann M; Creutzig U; Reinhardt D Leukemia; 2017 Dec; 31(12):2807-2814. PubMed ID: 28443606 [TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of de novo acute myeloid leukemia in Thai patients. Niparuck P; Chuncharunee S; Ungkanont A; Udomtrupayakul U; Aungchaisuksiri P; Rerkamnuatchoke B; Jootar S; Atichartakarn V J Med Assoc Thai; 2009 Sep; 92(9):1143-9. PubMed ID: 19772172 [TBL] [Abstract][Full Text] [Related]
20. Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia. Kalwinsky DK; Raimondi SC; Schell MJ; Mirro J; Santana VM; Behm F; Dahl GV; Williams D J Clin Oncol; 1990 Jan; 8(1):75-83. PubMed ID: 2295913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]